1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Concord Drugs
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
52W Low on Feb 11, 2025
-3.7
TTM PE Ratio
Negative PE TTM
-836.7
Price to Book Ratio
Low in industry
1
Dividend yield 1yr %
0
TTM PEG Ratio
Concord Drugs Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Concord Drugs Quarterly Revenue
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
10.8 Cr | 12.36 Cr | 11.69 Cr | 15.64 Cr | 12.78 Cr |
Concord Drugs Yearly Revenue
| Mar 2024 | Mar 2023 |
|---|---|
44.93 Cr | 52.09 Cr |
Concord Drugs Quarterly Net Profit/Loss
| Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|
0.23 Cr | 0.04 Cr | 0.03 Cr | -0.34 Cr | -0.24 Cr |
Concord Drugs Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 |
|---|---|
0.47 Cr | 0.99 Cr |
Concord Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
33.70
10Day EMA
33.70
12Day EMA
33.70
20Day EMA
34.20
26Day EMA
34.40
50Day EMA
35.30
100Day EMA
36.00
200Day EMA
36.60
5Day SMA
33.50
10Day SMA
33.30
20Day SMA
33.90
30Day SMA
34.90
50Day SMA
35.90
100Day SMA
36.30
150Day SMA
36.50
200Day SMA
37.00
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 1508 Rs | 1558 Rs |
Week Rs | 3406 Rs | 3742 Rs |
Month Rs | 4817 Rs | 6329 Rs |
Resistance & Support
34.19
Pivot
Resistance
First Resistance
35.25
Second Resistance
35.87
Third Resistance
36.93
Support
First Support
33.57
Second support
32.51
Third Support
31.89
Relative Strength Index
50.45
Money Flow Index
56.80
MACD
-0.71
MACD Signal
-0.83
Average True Range
2.94
Average Directional Index
26.35
Rate of Change (21)
-7.21
Rate of Change (125)
-5.02
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Veerhealth Care Ltd. | - | - | - | |
Concord Drugs Ltd. | - | - | - | |
Gujarat Inject (Kerala) Ltd. | - | - | - | |
38.75 | 38.45 | 78.48 | ||
Dipna Pharmachem Ltd. | - | - | - | |
Vilin Bio Med Ltd. | - | - | - | |
Mono Pharmacare Ltd. | - | - | - |
News
Concord Drugs Company background
Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Concord Drugs FAQs
How to buy Concord Drugs shares?
You can easily buy Concord Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
